GTR Home > Tests > Search results - PIK3R1[gene]

Apply filters

Showing tests for all 100 conditions

Compare labs

More test methods
  • Hide states

GTR test search results for 5295[geneid]

C Clinical test, R Research test

Showing 1 to 18 of 18 tests for 100 conditions in 11 labs

CImmunodeficiency type 36

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAgammaglobulinemia type 7, autosomal recessive

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSHORT syndrome

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFoundationOne®

Lab: Foundation Medicine, Inc. Cambridge, Massachusetts, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total targets (315)

CAgammaglobulinemia panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Total conditions (9)
Total targets (9)

CPIK3R1 sequencing

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CFoundationOne® Heme

Lab: Foundation Medicine, Inc. Cambridge, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • R RNA analysis
  • E Sequence analysis of select exons
Total targets (405)

CSolid Tumor Panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (40)
Total targets (62)

CAntibody deficiencies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (13)
Total targets (28)

CHemato-oncology chromosomal microarray

Methods
  • H Detection of homozygosity
  • D Deletion/duplication analysis
  • H Detection of homozygosity
Total conditions (23)
Total targets (93)

CPIK3R1 Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CPrimary Antibody Deficiency Panel, Sequencing (35 Genes) and Deletion/Duplication (26 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (37)
Total targets (35)

CAgammaglobulinemia Panel, Sequencing (9 Genes) and Deletion/Duplication (6 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (9)
Total targets (9)

CPIK3R1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSHORT syndrome (sequence analysis of PIK3R1 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

RSHORT syndrome

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

RSHORT Syndrome

Conditions
Test targets
Methods
  • S Mutation scanning of the entire coding region

Showing 1 to 18 of 18 tests for 100 conditions in 11 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.